
OsteoBites S1 Ep6: Osteosarcoma Research, J. Andrew Livingston, MD
MIB Agents OsteoBites ›40:14 | May 14th, 2020
MIB Agents Osteosarcoma Webinar Series OsteoBites Dr. Andrew Livingston shares an update on his osteosarcoma research, funded by MIB Agents: "CD73 The Next Immunotherapy Target for O...Show More
Recommendations